HPV Type Distribution in HIV Positive and Negative Women With or Without Cervical Dysplasia or Cancer in East Africa

BackgroundWomen living with HIV in sub-Saharan Africa are at increased risk to develop cervical cancer (CC), which is caused by persistent infection with 13 oncogenic human papilloma viruses (HR-HPVs). It is important to accurately identify and target HIV-positive women at highest risk to develop CC...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ruby Mcharo, Tessa Lennemann, John France, Liseth Torres, Mercè Garí, Wilbert Mbuya, Wolfram Mwalongo, Anifrid Mahenge, Asli Bauer, Jonathan Mnkai, Laura Glasmeyer, Mona Judick, Matilda Paul, Nicolas Schroeder, Bareke Msomba, Magreth Sembo, Nhamo Chiwerengo, Michael Hoelscher, Otto Geisenberger, Ralph J. Lelle, Elmar Saathoff, Leonard Maboko, Mkunde Chachage, Arne Kroidl, Christof Geldmacher
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/15bddb881e4d4fdc8d763d693956f2e8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:15bddb881e4d4fdc8d763d693956f2e8
record_format dspace
spelling oai:doaj.org-article:15bddb881e4d4fdc8d763d693956f2e82021-12-01T15:47:56ZHPV Type Distribution in HIV Positive and Negative Women With or Without Cervical Dysplasia or Cancer in East Africa2234-943X10.3389/fonc.2021.763717https://doaj.org/article/15bddb881e4d4fdc8d763d693956f2e82021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.763717/fullhttps://doaj.org/toc/2234-943XBackgroundWomen living with HIV in sub-Saharan Africa are at increased risk to develop cervical cancer (CC), which is caused by persistent infection with 13 oncogenic human papilloma viruses (HR-HPVs). It is important to accurately identify and target HIV-positive women at highest risk to develop CC for early therapeutic intervention.MethodsA total of 2,134 HIV+ and HIV− women from South-West Tanzania were prospectively screened for cervical cancer and precancerous lesions. Women with cervical cancer (n=236), high- and low-grade squamous intraepithelial lesions (HSIL: n=68, LSIL: n=74), and without lesion (n=426) underwent high-resolution HPV genotyping.ResultsEighty percent of women who were diagnosed with HSIL or LSIL were living with HIV. Any lesion, young age, HIV status, and depleted CD4 T cell counts were independent risk factors for HPV infections, which were predominantly caused by HR-HPV types. While multiple HR-HPV type infections were predominant in HIV+ women with HSIL, single-type infections predominated in HIV+ CC cases (p=0.0006). HPV16, 18, and 45 accounted for 85% (68/80) and 75% (82/110) of HIV+ and HIV− CC cases, respectively. Of note, HPV35, the most frequent HPV type in HSIL-positive women living with HIV, was rarely detected as a single-type infection in HSIL and cancer cases.ConclusionHPV16, 18, and 45 should receive special attention for molecular diagnostic algorithms during CC prevention programs for HIV+ women from sub-Saharan Africa. HPV35 may have a high potential to induce HSIL in women living with HIV, but less potential to cause cervical cancer in single-type infections.Ruby McharoTessa LennemannTessa LennemannJohn FranceLiseth TorresMercè GaríWilbert MbuyaWilbert MbuyaWolfram MwalongoAnifrid MahengeAsli BauerAsli BauerJonathan MnkaiLaura GlasmeyerMona JudickMatilda PaulNicolas SchroederBareke MsombaMagreth SemboNhamo ChiwerengoMichael HoelscherMichael HoelscherOtto GeisenbergerOtto GeisenbergerRalph J. LelleElmar SaathoffElmar SaathoffLeonard MabokoMkunde ChachageMkunde ChachageMkunde ChachageArne KroidlArne KroidlChristof GeldmacherChristof GeldmacherFrontiers Media S.A.articlehuman papilloma virus—HPVhuman immunodeficiency virus—HIVcervical cancercervical dysplasiahigh-grade intraepithelial lesionslow-grade intraepithelial lesionsNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic human papilloma virus—HPV
human immunodeficiency virus—HIV
cervical cancer
cervical dysplasia
high-grade intraepithelial lesions
low-grade intraepithelial lesions
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle human papilloma virus—HPV
human immunodeficiency virus—HIV
cervical cancer
cervical dysplasia
high-grade intraepithelial lesions
low-grade intraepithelial lesions
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Ruby Mcharo
Tessa Lennemann
Tessa Lennemann
John France
Liseth Torres
Mercè Garí
Wilbert Mbuya
Wilbert Mbuya
Wolfram Mwalongo
Anifrid Mahenge
Asli Bauer
Asli Bauer
Jonathan Mnkai
Laura Glasmeyer
Mona Judick
Matilda Paul
Nicolas Schroeder
Bareke Msomba
Magreth Sembo
Nhamo Chiwerengo
Michael Hoelscher
Michael Hoelscher
Otto Geisenberger
Otto Geisenberger
Ralph J. Lelle
Elmar Saathoff
Elmar Saathoff
Leonard Maboko
Mkunde Chachage
Mkunde Chachage
Mkunde Chachage
Arne Kroidl
Arne Kroidl
Christof Geldmacher
Christof Geldmacher
HPV Type Distribution in HIV Positive and Negative Women With or Without Cervical Dysplasia or Cancer in East Africa
description BackgroundWomen living with HIV in sub-Saharan Africa are at increased risk to develop cervical cancer (CC), which is caused by persistent infection with 13 oncogenic human papilloma viruses (HR-HPVs). It is important to accurately identify and target HIV-positive women at highest risk to develop CC for early therapeutic intervention.MethodsA total of 2,134 HIV+ and HIV− women from South-West Tanzania were prospectively screened for cervical cancer and precancerous lesions. Women with cervical cancer (n=236), high- and low-grade squamous intraepithelial lesions (HSIL: n=68, LSIL: n=74), and without lesion (n=426) underwent high-resolution HPV genotyping.ResultsEighty percent of women who were diagnosed with HSIL or LSIL were living with HIV. Any lesion, young age, HIV status, and depleted CD4 T cell counts were independent risk factors for HPV infections, which were predominantly caused by HR-HPV types. While multiple HR-HPV type infections were predominant in HIV+ women with HSIL, single-type infections predominated in HIV+ CC cases (p=0.0006). HPV16, 18, and 45 accounted for 85% (68/80) and 75% (82/110) of HIV+ and HIV− CC cases, respectively. Of note, HPV35, the most frequent HPV type in HSIL-positive women living with HIV, was rarely detected as a single-type infection in HSIL and cancer cases.ConclusionHPV16, 18, and 45 should receive special attention for molecular diagnostic algorithms during CC prevention programs for HIV+ women from sub-Saharan Africa. HPV35 may have a high potential to induce HSIL in women living with HIV, but less potential to cause cervical cancer in single-type infections.
format article
author Ruby Mcharo
Tessa Lennemann
Tessa Lennemann
John France
Liseth Torres
Mercè Garí
Wilbert Mbuya
Wilbert Mbuya
Wolfram Mwalongo
Anifrid Mahenge
Asli Bauer
Asli Bauer
Jonathan Mnkai
Laura Glasmeyer
Mona Judick
Matilda Paul
Nicolas Schroeder
Bareke Msomba
Magreth Sembo
Nhamo Chiwerengo
Michael Hoelscher
Michael Hoelscher
Otto Geisenberger
Otto Geisenberger
Ralph J. Lelle
Elmar Saathoff
Elmar Saathoff
Leonard Maboko
Mkunde Chachage
Mkunde Chachage
Mkunde Chachage
Arne Kroidl
Arne Kroidl
Christof Geldmacher
Christof Geldmacher
author_facet Ruby Mcharo
Tessa Lennemann
Tessa Lennemann
John France
Liseth Torres
Mercè Garí
Wilbert Mbuya
Wilbert Mbuya
Wolfram Mwalongo
Anifrid Mahenge
Asli Bauer
Asli Bauer
Jonathan Mnkai
Laura Glasmeyer
Mona Judick
Matilda Paul
Nicolas Schroeder
Bareke Msomba
Magreth Sembo
Nhamo Chiwerengo
Michael Hoelscher
Michael Hoelscher
Otto Geisenberger
Otto Geisenberger
Ralph J. Lelle
Elmar Saathoff
Elmar Saathoff
Leonard Maboko
Mkunde Chachage
Mkunde Chachage
Mkunde Chachage
Arne Kroidl
Arne Kroidl
Christof Geldmacher
Christof Geldmacher
author_sort Ruby Mcharo
title HPV Type Distribution in HIV Positive and Negative Women With or Without Cervical Dysplasia or Cancer in East Africa
title_short HPV Type Distribution in HIV Positive and Negative Women With or Without Cervical Dysplasia or Cancer in East Africa
title_full HPV Type Distribution in HIV Positive and Negative Women With or Without Cervical Dysplasia or Cancer in East Africa
title_fullStr HPV Type Distribution in HIV Positive and Negative Women With or Without Cervical Dysplasia or Cancer in East Africa
title_full_unstemmed HPV Type Distribution in HIV Positive and Negative Women With or Without Cervical Dysplasia or Cancer in East Africa
title_sort hpv type distribution in hiv positive and negative women with or without cervical dysplasia or cancer in east africa
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/15bddb881e4d4fdc8d763d693956f2e8
work_keys_str_mv AT rubymcharo hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT tessalennemann hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT tessalennemann hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT johnfrance hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT lisethtorres hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT mercegari hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT wilbertmbuya hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT wilbertmbuya hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT wolframmwalongo hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT anifridmahenge hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT aslibauer hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT aslibauer hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT jonathanmnkai hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT lauraglasmeyer hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT monajudick hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT matildapaul hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT nicolasschroeder hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT barekemsomba hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT magrethsembo hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT nhamochiwerengo hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT michaelhoelscher hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT michaelhoelscher hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT ottogeisenberger hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT ottogeisenberger hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT ralphjlelle hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT elmarsaathoff hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT elmarsaathoff hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT leonardmaboko hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT mkundechachage hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT mkundechachage hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT mkundechachage hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT arnekroidl hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT arnekroidl hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT christofgeldmacher hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
AT christofgeldmacher hpvtypedistributioninhivpositiveandnegativewomenwithorwithoutcervicaldysplasiaorcancerineastafrica
_version_ 1718404797918347264